首页> 美国卫生研究院文献>Clinical Medicine Insights. Case Reports >First Lung Transplantation in Jehovah’s Witness Patient in Latin America
【2h】

First Lung Transplantation in Jehovah’s Witness Patient in Latin America

机译:在拉丁美洲的耶和华见证人的首次肺移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung transplantation is a life-saving alternative for patients with end-stage lung disease. The procedure itself has a high risk of bleeding. Jehovah’s Witness patients refuse to accept blood products due to religious beliefs. A 48-year-old Jehovah’s Witness woman presented with an 8-year history of cough, dyspnea along with progressive worsening of her functional class and quality of life. A diagnosis of autoimmune interstitial lung disease was made, for which cyclophosphamide was administered without improvement of symptoms, and the patient was accepted as a transplant candidate. Transplantation was performed without complications, nor blood products requirement, intraoperative cell salvage was performed, and pharmacological agents were used preoperatively for bleeding prevention. The patient only developed anemia after administration of immunosuppressor therapy, which was treated with erythropoietin in the outpatient setting.
机译:肺移植是一种终末期肺病患者的救生替代品。程序本身具有高风险的流血。耶和华的见证患者因宗教信仰而拒绝接受血液产品。一个48岁的耶和华见证女子,伴随着8年的咳嗽历史,呼吸困难以及逐步恶化了她的功能阶级和生活质量。制备了自身免疫间质性肺病的诊断,用于施用环磷酰胺而不会改善症状,并且患者被接受为移植候选者。在没有并发症的情况下进行移植,也进行血液产品要求,进行术中细胞销存,并且术前使用药理学剂进行渗出。患者在施用免疫压缩机治疗后仅开发贫血,其在门诊设定中用促红细胞生成素治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号